Fruth Investment Management - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Fruth Investment Management ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2021$0
-100.0%
12,6000.0%0.00%
-100.0%
Q4 2020$31,000
-22.5%
12,600
-3.1%
0.01%
-31.2%
Q3 2020$40,000
+8.1%
13,0000.0%0.02%0.0%
Q2 2020$37,000
+2.8%
13,0000.0%0.02%
-11.1%
Q1 2020$36,000
-14.3%
13,0000.0%0.02%
+12.5%
Q4 2019$42,000
+50.0%
13,0000.0%0.02%
+45.5%
Q3 2019$28,000
-9.7%
13,000
+30.0%
0.01%
-8.3%
Q2 2019$31,000
-16.2%
10,0000.0%0.01%
-25.0%
Q1 2019$37,000
+27.6%
10,000
-2.9%
0.02%
+14.3%
Q4 2018$29,000
-14.7%
10,300
+1.0%
0.01%
-12.5%
Q3 2017$34,000
+36.0%
10,2000.0%0.02%
+33.3%
Q2 2017$25,000
+8.7%
10,200
-1.0%
0.01%
+9.1%
Q1 2017$23,000
+9.5%
10,3000.0%0.01%
+10.0%
Q4 2016$21,000
-43.2%
10,300
-8.8%
0.01%
-44.4%
Q3 2016$37,000
+2.8%
11,300
-2.6%
0.02%
+5.9%
Q2 2016$36,000
-5.3%
11,6000.0%0.02%
-10.5%
Q1 2016$38,000
-9.5%
11,600
-2.5%
0.02%
-9.5%
Q4 2015$42,000
-22.2%
11,900
+9.2%
0.02%
-25.0%
Q3 2015$54,000
-22.9%
10,9000.0%0.03%
-15.2%
Q2 2015$70,000
-7.9%
10,9000.0%0.03%0.0%
Q1 2015$76,000
-9.5%
10,9000.0%0.03%
-8.3%
Q4 2014$84,000
+3.7%
10,9000.0%0.04%0.0%
Q3 2014$81,000
-4.7%
10,900
+7.4%
0.04%
-10.0%
Q1 2014$85,000
-1.2%
10,150
-1.0%
0.04%
-2.4%
Q4 2013$86,000
+1.2%
10,250
-4.7%
0.04%
-8.9%
Q3 2013$85,000
+1.2%
10,750
-1.8%
0.04%
-6.2%
Q2 2013$84,00010,9500.05%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,585,500$3,710,0001.36%
SMH CAPITAL ADVISORS INC 83,369$195,0000.32%
West Family Investments, Inc. 338,141$791,0000.20%
Matarin Capital Management, LLC 927,289$2,169,856,0000.16%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$33,0000.12%
Alambic Investment Management, L.P. 163,200$382,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 1,760,376$4,119,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 5,677,647$13,286,0000.08%
Zebra Capital Management LLC 67,892$159,0000.07%
Fortis Advisors, LLC 45,602$107,0000.06%
View complete list of PDL BIOPHARMA INC shareholders